Factor IX (human coagulation factor IX)
/ Hemobras
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 21, 2020
Providing personalized care for bleeding disorders
(News-Medical)
- P3, N=115; PROPEL (NCT03732820); Sponsor: AstraZeneca; CONTINUATION (NCT01945593); Sponsor: Shire; "An interview with Dr. Carmen Escuriola-Ettingshausen MD...on providing personalized care for bleeding disorders such as hemophilia and von Willebrand disease....Of course, personalized prophylaxis usually aims to prevent all bleeds. But from a world-wide perspective, personalization of therapy can also be implemented with a lower amount of resources, for example in developing countries."
Interview • P3 data
1 to 1
Of
1
Go to page
1